Meditold Lab Announces Human Trial Results for ‘HUQ Cream’

Meditold Lab has unveiled the results of human trials for their specialized anti-blemish product, ‘HUQ Cream.’

HUQ Cream, incorporating Meditold Lab’s unique formulation technology, has successfully exceeded the benchmarks in all aspects of human trials conducted on adult women aged 32 to 62. These trials demonstrated significant improvements in reducing blemishes, pigment discoloration, and melanin area.

According to findings from a reputable clinical institution, the use of HUQ Cream for just two weeks visibly improved blemishes and pigment discoloration. Furthermore, the application of HUQ Cream also proved effective in reducing melanin area and enhancing skin brightness.

An official spokesperson stated, “We obtained unanimous results indicating 100% satisfaction with the improvement effects of HUQ Cream through qualitative assessments. It is evident that participants in the clinical trials have noticed substantial benefits.”

The core technology behind HUQ Cream, known as ‘HUQ,’ is Meditold Lab’s proprietary Bio-Care component.

Media Contact
Company Name: Issue Lab
Contact Person: Min Gi, KANG
Email: Send Email
Country: South Korea
Website: https://m.post.naver.com/my.naver?memberNo=5705504


Posted

in

by

Tags: